Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

Abstract Introduction Neurodegeneration appears to be the biological mechanism most proximate to cognitive decline in Alzheimer's disease. We test whether t‐tau and alternative biomarkers of neurodegeneration—neurogranin and neurofilament light protein (NFL)—add value in predicting subclinical...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew P. Merluzzi, Nicholas M. Vogt, Derek Norton, Erin Jonaitis, Lindsay R. Clark, Cynthia M. Carlsson, Sterling C. Johnson, Sanjay Asthana, Kaj Blennow, Henrik Zetterberg, Barbara B. Bendlin
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Alzheimer's disease
Biomarkers
Cognition
Neurodegeneration
Amyloid
Cognitive decline
Online Access:https://doi.org/10.1016/j.trci.2019.02.004
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1016/j.trci.2019.02.004

Similar Items